Are the phenotypes of preneoplastic lesions of significance for cancer prevention? 1. liver

Asian Pacific Journal of Cancer Prevention

Volumn 2, Issue 1, 2001, Pages 27-42

  Moore, Malcolm A ^a   Tatematsu, Masae ^b  

^a APOCP Training Centre   (Thailand)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873506425     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (202)

1. Agius L, Alberti KG (1985). Regulation of flux through pyruvate dehydrogenase and pyruvate carboxylase in rat hepatocytes. Effects of fatty acids and glucagon. Eur J Biochem, 152, 699-707.
2. Ahlberg J, Yucel T, Eriksson L, Glaumann H (1987). Characterization of the proteolytic compartment in rat hepatocyte nodules. Virchows Arch B Cell Pathol, 53, 79-88.
3. Ahluwalia M, Farber E (1984). Alterations in glutathione status in early hyperplastic liver nodules. Proc Am Assoc Cancer Res, 25, 15.
4. Alexandre K, Jacobovitz D, Garland P (1990). Immunohistochemical detection of c-myc and cerb A products in diethylnitrosamine-induced preneoplastic and neoplastic liver lesions in rats. Carcinogenesis, 11, 1189-94.
5. Andersen D K, Ruiz C L, Durant C F (1994). Insulin regulation of hepatic transporter protein is impaired in chronic pancreatitis. Ann Surg, 219, 679-87.
6. Andersson G N, Rissler P, Eriksson L C (1988). Asialoglycoprotein receptors in rat liver nodules. Carcinogenesis, 9, 1623-28.
7. Andersson G N, Torndal U-B, Eriksson L C (1989). Decreased vacuolar acidification capacity in drug-resistant rat liver preneoplastic nodules. Cancer Res, 49, 3765-69.
8. Baba M, Yamamoto R, Iishi H, Tatsuda M, Wada A (1989). Role of glucose-6-phosphate dehydrogenase in enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by Nnitrosomorpholine. Int J Cancer, 43, 892-895.
9. Bannasch P, Hacker H J, Klimek F, Mayer D (1984). Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul, 22, 97-121.
10. Bannasch P, Khoskou IN, Hacker HJ, et al (1995). Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks. Cancer Res, 55, 3318-30.
11. Bannasch P, Klimek F, Mayer D (1997). Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr, 29, 303-13.
12. Bannasch P, Mayer D, Hacker H J (1980). Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta, 605, 217-45.
13. Bannasch P, Mayer D,Venske G (1979). Pränatale Induktion von hepatocellulären Glykogenspeicherarealen und Tumoren bei Mäusen durch Äthylnitrosoharnstoff. Virchows Arch B, 30, 143-60.
14. Bannasch P, Papenburg J, Ross W (1972). Cytomorphologische und morphometrische Studien der Hepatocarcinogenese. I. Reversible und irreversible Veränderungen am Cytoplasma der Leberpaarenchymzellen bei Nitrosomorpholin-vergifteten Ratten. Z Krebsforsch, 77, 108-33.
15. Barnett C R, Abbott R A, Bailey C J, Flatt P R, Ioannides C (1992). Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesitydiabetes. Biochem Pharmacol, 43, 1868-71.
16. Becker R A, Planche-Martel G (1986). Enhanced O6-methylguanine-DNA alkyltransferase in rat liver nodules. Cancer Lett., 32, 243-51.
17. Beer D G, Schwarz M, Sawada N, Pitot H C (1986). Expression of H-ras and c-myc protooncogenes in isolated g-glutamyl transpeptidase-positive rat hepatocytes and hepatocellular carcinomas induced by diethylnitrosamine. Cancer Res, 46, 2435-41.
18. Beer D G, Neveu M J, Paul D L, Rapp U R, Pitot H C (1988). Expression of the c-raf protooncogene. g-glutamyl transpeptidase and gap junction protein in rat liver neoplasms. Cancer Res,48, 1610-17.
19. Benedetti A, Malvaldi G, Fulceri R, Comporti M (1984). Loss of lipid peroxidation as a histochemical marker for preneoplastic hepatocellualr foci of rats. Cancer Res, 44, 5712-17.
20. Betschart J M, Virji M A, Gupta C, Shinozuka H (1988). Alterations induced by phenobarbital, a liver tumr promoter, in hepatocyte receptors for insulin and glucagon and glycogen metabolism. Carcinogenesis, 9, 1289-94.
21. Bianchi L (1993). Glycogen storage disease I and hepatocellular tumors. Eur J Paediatr, 152, S63-S70.
22. Bock K W, Lilienblum W, Pfeil H, Eriksson L C (1982). Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res, 42, 3747-52.
23. Brunn H, Schmidt E, Reinacher M, et al (1987). Histology and histochemistry of the liver of chickens after DEN-induced hepatocarcinogenesis and ingestion of low chlorinated biphenyls. Arch Toxicol, 60, 337-42.
24. Buchmann A, Bauer-Hofmann R, Mahr J, et al (1991). Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis. Proc Natl Acad Sci USA, 88, 911-5.
25. Buchmann A, Kuhlmann W, Schwarz M, et al (1985). Regulation and expression of four cytochrome P-450 isoenzymes, NADPHcytochrome P450 reductase, the glutathione S-transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis, 6, 513-21.
26. Burcelin R, Eddouks M, Kande J, Assan R, Girard J (1992). Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. Biochem J, 288, 675-9.
27. Cameron R, Sweeney G D, Jones K, Lee G, Farber E (1976). A relative deficiency of cytochrome P-450 and aryl hydrocarbon (benzo[a]pyrene)hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Res, 36, 3888-93.
28. Cariani E, Dubois N, Lasserre C, Briand P, Brechot C (1991). Insulin-like growth factor II (IGF-II) mRNA expression during hepatocarcinogenesis in transgenic mice. J Hepatol, 13, 220-6.
29. Carnovale C E, Monti J A, Catania V A, Carrillo M C (1990). Possible role of blood insulin levels on glutathione S-transferase from different tissues of male rats. Can J Physiol Pharmacol, 68, 170-3.
30. Carrillo M C, Monti J A, Favre C, Carnovale C E (1995). Acute regulation of hepatic glutathione S-transferase by insulin and glucagon. Toxicology Lett, 76, 105-11.
31. Chen Z-Y, L Y-F, He C-Y, White C C, Eaton D L (1994). Inhibition of cell proliferation by ciprofibrate in glutathione S-transferases P1-1-positive rat hepatic hyperplastic nodules. Cancer Res, 54, 2622-29.
32. Citti L, Mariani L, Mengozzi M, Malvaldi G (1990). DNA repair systems in early and persistent hepatocyte nodules in the rat. J Cancer Res Clin Oncol, 116, 156-8.
33. Coni P, Pang J, Pichiri-Coni G, Hsu S, Rao P M, Rajalakshmi S, Sarma D S R (1992). Hypomethylation of the b-hydroxy-bmethyl-glutaryl coenzyme A reductase gene and its expression during hepatocarcinogenesis in the rat. Carcinogenesis, 13, 497-9.
34. Corcos D, Defer N, Raymondjean M, et al (1984). Correlated increase of the expression of the c-ras genes in chemicallyinduced hepatocarcinomas. Biochem Biophys Res Commun, 122, 258-64.
35. Corral M, Tichonicky L, Guguen-Guillouzo C, et al (1985). Expression of c-fos oncogene during hepatocarcinogenesis, liver regeneration and in synchronized HTC cells. Exp Cell Res, 160, 427-34.
36. Daoust R (1979). Histochemical comparison of focal losses of RNase and ATPase activities in preneoplastic rat livers. J Histochem Cytochem, 27, 653-6.
37. Davis B B, Magge S, Mucenski C G, Drake R L (1988). Insulinmediated post-transcriptional regulation of hepatic malic enzyme and albumin RNAs. Biochem Biophys Res Commun, 154, 1081-7.
38. De Canniere D, Ravelingien N, Preat V, Dehaye J P, Pector J C (1992). Adenylate cyclase activity in crude liver membranes during chemical carcinogenesis in portacaval shunted rats. Carcinogenesis, 13, 241-6.
39. Deml E, Oesterle D (1980). Histochemical demonstration of enhanced glutathione content in enzyme-altered islands induced by carcinogens in rat liver. Cancer Res, 40, 490-1.
40. Ding V D-H, Cameron R, Pickett C B (1990). Regulation of microsomal, xenobiotic epoxide hydrolase messenger RNA in persistent hepatocyte nodules and hepatomas induced by chemical carcinogens. Cancer Res, 50, 256-60.
41. Dombrowski F, Bannasch P, Pfeifer U (1997). Hepatocellular neoplasms induced by low-number pancreatic transplants in streptozotocin diabetic rats. Am J Pathol, 150, 1071-87.
42. Dombrowski F, Filsinger E, Bannasch P, Pfeifer U (1996). Hyperproliferative liver acini induced in diabetic rats by portalvein islet isografts resemble preneoplastic hepatic foci in their enzyme pattern. Am J Pathol, 148, 1249-56.
43. Dombrowski F, Lehringer-Polzin M, Pfeifer U (1994). Hyperproliferative liver acini after intraportal islet transplantation in streptozotocin-induced diabetic rats. Lab Invest, 71, 688-99.
44. Dombrowski F, Klotz L, Hacker HJ, et al (2000). Hyperproliferative hepatocellular alterations after intraportal transplantation of thyroid follicles. Am J Pathol, 156, 99-113
45. Dragani T, Manenti G, Della Porta G, Gattoni-Celli S, Weinstein I B (1986). Expression of retroviral sequences and oncogenes in murine hepatocellular tumors. Cancer Res, 46, 1915-19.
46. Ehemann V, Mayer D, Hacker H J, Bannasch P (1986). Loss of adenylate cyclase activity in preneoplastic and neoplastic lesions induced in rat liver by N-nitrosomorpholine. Carcinogenesis, 7, 563-73.
47. Enomoto K, Ying T S, Griffin M J, Farber E (1981). Immunohistochemical study of epoxide hydrolase during experimental liver carcinogenesis. Cancer Res, 41, 3281-7.
48. Enzmann H, Ohlhauser D, Enzmann H et al (1989). Unusual histochemical pattern in preneoplastic hepatic foxci characterized by hyperactivity of several enzymes. Virchows Arch B Cell Pathol, 57, 99-108.
49. Eriksson L C, Andersson G N (1992). Membrane biochemistry and chemical hepatocarcinogenesis. Crit Rev Biochem Mol Biol, 27, 1-55.
50. Eriksson L C, Torndal U-B, Andersson G N (1983). Isolation and characterization of endoplasmic reticulum and Golgi apparatus from hepatocyte nodules in male Wistar rats. Cancer Res, 43, 3335-47.
51. Eriksson L C, Torndal U-B, Andersson G N (1986). The transferrin receptor in hepatocyte nodules: binding properties, subcellular distribution and endocytosis. Carcinogenesis, 7, 1467-74.
52. Estadella M D, Pujol M J, Domingo J (1984). Enzyme pattern and growth rate of liver preneoplastic clones during carcinogenesisby diethylnitrosamine. Oncology, 41, 276-9.
53. Esumi M, Aritaka T, Arii M, et al (1986). Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res, 46, 5767-71.
54. Farber E (1956). Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene and 3'-methyl-4-dimethylaminoazobenzene. Cancer Res, 16, 142-8.
55. Farber E (1985). Pre-cancerous steps in carcinogenesis. Their physiological adaptive nature. Biochem Biophys Acta, 738, 171-180.
56. Farber E, Parker S, Gruenstein M (1976). The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some carcinogens. Cancer Res, 36, 3879-87.
57. Fischer G, Hartmann H, Droese M, Schauer A, Bock K W (1986). Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contaceptives. Virchows Arch B, 50, 321-37.
58. Fischer G, Ruschenburg I, Eigenbrodt E, Katz N (1987). Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of rat liver. J Cancer Res Clin Oncol, 113, 430-436.
59. Fischer G, Ullrich D, Katz N, Bock K W, Schauer A (1983). Immunohistochemical and biochemical detection of uridindiphosphate-glucuronyl-transferase (UDP-GT) activity in putative preneoplastic liver foci. Virch Arch B [Cell Pathol], 42, 193-200.
60. Fitzgerald D, Mesnil M, Oyamada M, et al (1989) Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis. J Cell Biochem, 41, 97-102.
61. Flodby P, Liao D-Z, Blanck A, Xantopoulos K G H, Porsch-Haellstroem I (1995). Expression of the liver-enriched transcription factors C/EBPa, C/EBPb, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol Carcinogenesis, 12, 103-9.
62. Fontaniere B, Daoust R (1973). Histochemical studies on nuclease activity and neoplastic transformation in rat liver during diethylnitrosamine carcinogenesis. Cancer Res, 33, 3108-11.
63. Fraslin J-M, Kneip B, Vaulont S, et al (1985). Dependence of hepatocyte-specific gene expression on the cell-cell interactions in primary culture. EMBO J, 4, 2487-91.
64. Galand P, Jacobovitz D, Alexandre K (1988). Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats. Int. J Cancer, 41, 155-161.
65. Garcia-Jimenez C, Benito B, Jolin T, Santisteban P (1994). Insulin regulation of malic enzyme gene expression in rat liver: evidence for nuclear proteins that bind to two putative insulin response elements. Mol Endocrinol, 8, 1361-9.
66. Gerbracht U, Eigenbrodt E, Simile M M, et al (1993). Effect of Sadenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. Anticancer Res., 13, 1965-72.
67. Goodridge A G, Back D W, Wilson S B, Goldman M J (1986). Regulation of genes for enzymes involved in fatty acid synthesis. Ann N Y Acad Sci, 478, 46-62.
68. Granner D, Pilkis S (1990). The genes of hepatic glucose metabolism. J Biol Chem, 265, 10173-6.
69. Grasl-Kraupp B, Huber W, Just W, Gibson G, Schulte-Hermann R (1993a). Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat livertreated with the peroxisomal proliferator nafenopin. Carcinogenesis, 14, 1007-12.
70. Grasl-Kraupp B, WaldhörT, Huber W, Schulte-Hermann R (1993b). Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisomal proliferator nafenopin or with phenobarbital. Carcinogenesis, 14, 2407-12.
71. Greene H L (1982). Glycogen storage disease. Semin Liver Dis, 2, 291-301.
72. Grobholz R, Hacker H J, Thorens B, Bannasch P (1993), Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis. Cancer Res, 53, 4204-11.
73. Hacker H J, Moore M A, Mayer D, Bannasch P (1982). Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis, 3, 1265-72.
74. Harada T, Maronpot R R, Morris R W, Boorman G A (1989). Observation on altered hepatocellular foci in national toxicology program two-year carcinogenicity studies in rats. Toxicol Pathol, 17, 690-706.
75. Harris L, Preat V, Farber E (1987). Patterns of ligand binding to normal, regenerating, preneoplastic, and neoplastic rat hepatocytes. Cancer Res, 47, 3954-8.
76. Hatayama I, Yamada Y, Tanaka K, Ichihara A, Sato K (1991). Induction of glutathione S-transferase P-form inprimary cultured rat hepatocytes by epidermal growth factor and insulin. Jpn J Cancer Res, 82, 807-14.
77. Häussinger D, Lang F, Gerok W (1994). Regulation of cell function by the cellular hydration state. Am J Physiol, 267, E343-55.
78. Hsieh L L, Shinozuka H, Weinstein I B (1991). Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisomal proliferator. Br J Cancer, 64, 815-20.
79. Huber B E, Heilman C A, Thorgeirsson S S (1989), Poly(A) RNA levels of growth-, differentiation- and transformation-associated genes in the progressive development of hepatocellular carcinoma in the rat. Hepatology, 9, 756-62.
80. Ikegami T, Natsumeda Y, Weber G (1986). Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas. Cancer Res, 46, 3838-41.
81. Janossy L, Zalatnai A, Lapis K (1986). Quantitative light microscopic study on the distribution of Kupffer cells during chemical hepatocarcinogenesis in the rat. Carcinogenesis, 7, 1365-9.
82. Johansson S, Andersson N, Andersson G (1990). Pretranslational and posttranslational regulation of the EGF-receptor during the prereplicative phase of liver regeneration. Hepatology, 12, 533-7.
83. Jones D E Jr, Evces S, Lindahl R (1984). Expression of tumor associated aldehyde dehydrogenase during rat hepatocarcinogenesis using the resistant hepatocyte model. Carcinogenesis, 5, 1679-87.
84. Kanamoto R, Su Y, Pitot H C (1991). Effects of glucose, insulin, and cAMP on transcription of the serine dehydratase gene in rat liver. Arch Biochem Biophys, 288, 562-6.
85. Karhunen P J, Pentilla A (1987). Preneoplastic lesions in human liver. Hepato-Gastroenterol, 34, 10-5.
86. Kato T, Imaida K, Ogawa K, et al (1993). Three-dimensional analysis of glutathione S-transferase placental form-positive lesion development in early stages of rat hepatocarcinogenesis. Jpn J Cancer Res, 84, 1252-7.
87. Kitagawa T (1971). Histochemical analysis of hyperplastic lesions and hepatomas of the liver fed 2-fluorenylacetamide. Gann, 62, 207-16.
88. Kitagawa T (1976). Sequential phenotypic changes in hyperplastic areas during hepatocarcinogenesis in the rat. Cancer Res, 356, 2534-9.
89. Kitagawa T, Pitot H C (1975). The regulation of serine dehydratase and glucose-6-phosphatase in hyperplastic nodules of rat liver during diethylnitrosamine and N-2-fluorenylacetamide feeding. Cancer Res, 35, 1075-84.
90. Kitahara A, Satoh K, Nishimura K, et al (1984) Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarciniogenesis. Cancer Res, 44, 2698-703.
91. Kitahara A, Yamazaki T, Ishikawa T, Camba E A, Sato K (1983). Changes in activities of glutathione peroxidase and glutathione reductase during chemical hepatocarcinogenesis in the rat. Gann, 74, 649-55.
92. Klimek F, Bannasch P (1989). Biochemical microanalysis of aglucosidase activity in preneoplastic and neoplastic lesions induced in rats by N-nitrosomorpholine. Virchows Arch B Cell Pathol, 57, 245-50.
93. Klimek F, Bannasch P (1990). Biochemical microanalysis of pyruvate kinase activity in preneoplastic and neoplastic liver lesions induced in rats by N-nitrososmorpholine. Carcinogenesis, 11, 1377-80.
94. Klimek F, Bannasch P (1993). Isoenzyme shift from glucokinase to hexokinase is not an early but a late event in hepatocarcinogenesis. Carcinogenesis, 14, 1857-61.
95. Klimek F, Mayer D, Bannasch P (1984). Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine. Carcinogenesis, 5, 265-8.
96. Klimek F, Moore M A, Schneider E, Bannasch P (1988). Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide-induced neoplastic nodules of rat liver. Histochemistry, 90, 37-42.
97. Klotz L, Hacker HJ, Klingmüller D, et al (2000). Hepatocellular alterations after intraportal transplantation of ovarian tissue in ovariectomized rats.Am J Pathol, 156, 1613-26.
98. Kraupp-Grasl B, Huber W, Putz B, Gerbracht U, Schulte-Hermann R (1990). Tumor promotion by the peroxisome proliferator nafenopin involving a specific type of altered foci in rat liver. Cancer Res, 50, 3701-8.
99. Krutovskikh V A, Oyamada M, Yamasaki H (1991). Sequential changes of gap-junctional intercellular communications during multi-stage rat liver carcinogenesis: direct measurement of communication in vivo. Carcinogenesis, 12, 1701-6.
100. Laconi E, Sarma D S R, Pani P (1992). Rat hepatocyte nodules are resistant to the necrogenic effect of D-galactosamine. Carcinogenesis, 13, 2459-61.
101. Lagopoulos L, Sunahara GI, Würzner H, Dombrowsky I, Stalder R (1991). The effects of alternating dietary restriction and ad libitum feeding of mice on the development of diethylnitrosamine-induced liver tumours and its correlation to insulinaemia. Carcinogenesis, 12, 311-5.
102. La Porta C A M, Comolli R (1994). Membrane and nuclear protein kinase C activation in the early stages of diethylnitrosamineinduced rat hepatocarcinogenesis. Carcinogenesis, 15, 1743-7.
103. Ledda-Columbano G M, Columbano A, Dessi S, et al (1985). Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules. Carcinogenesis, 6, 1371-3.
104. Letiexhe M R, Scheen A J, Gerard P L, et al (1993). Insulinsecretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab, 77, 1263-8.
105. Levin W, Lu A Y H, Thomas P E, et al (1978). Identification of epoxide hydrolase as the preneoplastic antigen in rat liver hyperplastic antigen in rat liver hyperplastic nodules. Proc Natl Acad Sci USA, 75, 3240-3.
106. Lu S C, Ge J L, Kuhlenkamp J, Kaplowitz N (1992). Insulin and glucocorticoid dependence of hepatic gamma-glutamylcysteine synthetase and glutathione synthesis in the rat. Studies in cultured hepatocytes and in vivo. J Clin Invest, 90, 524-32.
107. Maltese W A (1990). Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J, 4, 3319-28.
108. Manos P, Nakayama R, Holten D (1991). Regulation of glucose-6-phosphate dehydrogenase synthesis and mRNA abundancein cultured rat hepatocytes. Biochem J, 276, 245-50.
109. Marsman D S, Popp J A (1994). Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis, 15, 111-7.
110. Mayer D, Metzger C, Leonetti P, et al (1998). Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int J Cancer, 79, 232-40.
111. Mehta R (1995). The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis. Cancer Letters, 93, 85-102.
112. Metzger C, Mayer D, Hoffmann H, et al (1995). Sequential appearance and ultrastructure of amphophilic foci, adenomas and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone (DHEA). Toxicol Pathol, 23, 591-605.
113. Miller R T, Cattley R C, Marsman D S, Lyght O, Popp J A (1995). TGFα is differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Carcinogenesis, 16, 77-82.
114. Mohan C, Memon R A, Bessman S P (1991). Differential effects of insulin, epinephrine, and glucagon on rat hepatocyte mitochondrial activity. Arch Biochem Biophys, 287, 18-23.
115. Moore M A, Mayer D, Bannasch P (1983). The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with Nnitrosomorpholine. Carcinogenesis, 3, 1429-36.
116. Moore M A, Nakagawa K, Satoh K, Ishikawa T, Sato K (1987). Single GST-P positive liver cells - putative initiated hepatocytes. Carcinogenesis, 8, 483-6.
117. Moore M A, Nakamura T, Thamavit W, Ichihara A, Ito N (1986). Immunohistochemically demonstrated suppressed expression of tryptophan oxygenase, a marker for liver differentiation, within putative preneoplastic rat liver lesions. Carcinogenesis, 7, 1393-6.
118. Moore MA, Park CB, Tsuda H (1998a). Soluble and insoluble fiber influences on cancer development. Crit. Rev. Hematol Oncol, 27, 229-42.
119. Moore MA, Park CB, Tsuda H (1998b) Implications of the hyperinsulinemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev, 7, 89-107.
120. Moore MA, Park CB, Tsuda H (1998c) Physical exercise: a pillar for cancer prevention. Eur J Cancer Prev, 7, 177-193
121. Moore M A, Weber E, Bannasch P (1988). Modulating influence of dehydroepiandrosterone administration on the morphology and enzyme phenotype of dimethylaminoazobenzene-induced hepatocellular foci and nodules. Virch Arch B Cell Pathol, 55, 337-43.
122. Müller O, Frech M, Gideon P, Wittinghofer A, Schwarz M (1992).Differences in GTPase-activating protein between liver tumors and normal tissue in mice. Oncogene, 7, 1407-12.
123. Munnich A, Reach M J, Vaulont G, Simon M P, Kahn A (1984). In vivo hormonal control of L-type pyruvate kinase expression. Effects of glucagon, cyclic AMP, insulin, cortisone and thyroid hormones on the dietary induction of mRNAs in the liver. J Biol Chem, 259, 10228-31.
124. Nagasaka Y, Kaku K, Nakamura K, Kaneko T (1994). cAMP inhibits the insulin-stimulated mitogen-activated protein kinase pathway in rat hepatoma H4EII cells. Biochem Biophys Res Commun, 202, 1104-12.
125. Nagy P, Evarts R P, Marsden E (1988). Cellular distribution of cmyc transcripts during chemical hepatocarcinogenesis in rat. Cancer Res, 48, 5522-7.
126. Nakamura T, Niimi S, Nawa K, et al (1987). Multihormonal regulation of transcription of the tryptophan 2,3-dioxygenase gene in primary cultures of adult rat hepatocytes with special reference to the presence of a transcriptional protein mediating the action of glucocorticoids. J Biol Chem, 262, 727-33.
127. Nakamuta M, Ohashi Mm, Goto K, et al (1993) Diabetes mellitusassociated glyccogen stroage hepatomegaly: report of a case and review of the Jaspanese literature. Fukuoka Igaku Zasshi, 84, 354-8.
128. Nakano H, Hatayama I, Satoh K, et al (1994) c-Jun expression in single cells and preneoplastic foci induced by diethylnitrosamine in B6C3F1 mice: comparison with the expression of pi-class glutathione S-transferase. Carcinogenesis, 15, 1853-7.
129. Nakatukasa H, Evarts R P, Hsia C-C, Thorgeirsson S S (1990). Transforming growth factor-beta and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest, 63, 171-5.
130. Nehrbass D, Klimek F, Bannasch P (1998). Overexpression of insulin receptor substrate-1emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol, 152, 341-5.
131. Nehrbass D, Klimek F, Bannasch P, Mayer D (1999). Insulin receptor substrate-1 is over-expressed in glycogenotic but not in amphophilic preneoplastic hepatic foci induced in rats by Nnitrosomorpholine and dehydroepiandrosterone. Cancer Lett, 140, 75-9.
132. Ness G C, Zhao Z, Wiggins L (1994). Insulin and glucagon modulate hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by affecting immunoreactive protein levels. J Biol Chem, 269, 29168-72.
133. Nilsson H, Eriksson LC (1994). Growth factor induced mitogenic effects and inositol phosphate responses in primary hepatocyte cultures from normal liver and rat liver nodules. Carcinogenesis, 15, 1821-6.
134. Noguchi T, Iritani N, Tanaka T (1992). Molecular mechanism of induction of key enzymes related to lipogenesis. Proc Soc Exp Biol Med, 200, 206-9.
135. Norstedt G, Levinovitz A, Moeller C, Eriksson L C, Andersson G (1988). Expression of insulin-like growth factor-I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat. Carcinogenesis, 9, 209-13.
136. Ober S, Zerban H, Spiethoff A, et al (1994). Preneoplastic foci of altered hepatocytes induced in rats by irradiation with a-particles of Thorotrast and neutrons. Cancer Letters, 83, 81-8.
137. Ogawa H, Itoshima T, Ito T, et al (1983). Absence of Kupffer cells in carcinogen induced liver hyperplastic nodules: demonstration by intravenous injection of Indian ink. Acta Med Okayama, 37, 79-84.
138. Ogiso T, Tatematsu M, Tamano S, Hasegawa R, Ito N (1990).Correlation between medium-term liver bioassay system data and results of long-term testing in rats. Carcinogenesis, 11, 561-6.
139. Olsson J M, Schedin S, Teclebrhan H, Eriksson L C, Dallner G (1995). Enzymes of the mevalonate pathway in rat liver nodules induced by 2-acetylaminofluorene treatment. Carcinogenesis, 16, 599-605.
140. Ordway N K, Stout L C (1973). Intrauterine growth retrdation, jaundice and hypoglycemia in a neonate. J Pedriatr, 83, 867-74.
141. Ozaki K, Kato T, Asamoto M (1993). Decreased dimethylnitrosamine-induced O6- and N7-methyldeoxyguanosine levels correlate with development and progression of lesions in rat hepatocarcinogenesis. Jpn J Cancer Res, 84, 1245-51.
142. Park O J, Cesar D, Faix D, et al (1992). Mechanisms of fructoseinduced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem J, 282, 757.
143. Pearline R V, Lin Y-Z, Shen K J, et al (1996). Alterations in enzymatic functions in hepatocytes and hepatocellular carcinomas from ras-transduced livers resemble the effects of insulin. Hepatology, 24, 838-48.
144. Pitot H C (1990). Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol, 30, 465-500.
145. Pitot H C (1996). Stage-specific gene expression during hepatocarcinogenesis in the rat. J Cancer Res Clin Oncol, 122, 257-265.
146. Porsch-Haellstroem I, Blanck A, Eriksson L C, Gustafsson J-A (1989). Expression of the c-myc, c-fos and c-ras Ha protooncogenes during sex-differentiated rat liver carcinogenesis in the resistant hepatocyte model. Carcinogenesis, 10, 1793-1800.
147. Rabes H M, Bucher T, Hartmann A, Linke I, Dunnwald M (1982). Clonal growth of carcinogen-induced enzyme deficient preneoplastic cell populations in mouse liver. Cancer Res, 42, 3220-7.
148. Rao M S, Ide H, Yeldani A V, Kumar S, Reddy J K (1994). Expression of peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase enzyme and its mRNA in peroxisome proliferator-induced liver tumors. Carcinogenesis, 15, 2619-22.
149. Rao M S, Tatematsu M, SubbArao V, Ito N, Reddy J K (1986). Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of the rat liver for placental form of glutathione S-transferase and g-glutamyl transpeptidase. Cancer Res, 46, 5287-90.
150. Reed W D, Baab P J, Hawkins R L, Ozand P T (1984). The effects of insulin and glucagon on ketone-body turnover. Biochem J, 221, 439-44.
151. Richmond R E, Pereira M A, Carter J H, Carter H W, Long R E (1988). Quantitative and qualitative immunohistochemical detection of myc and src oncogene proteins in normal, nodule and neoplastic rat liver. J Histochem Cytochem, 36, 179-184.
152. Roomi M W, Ho R K, Sarma D S R, Farber E (1985). A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res, 45, 564-71.
153. Ruebner B H, Michas C, Kanayama R, Bannasch P (1976). Sequential hepatic histologic and histochemical changes produced by diethylnitrosamine in the rhesus monkey. J Natl Cancer Inst, 57, 1261-8.
154. Saez J C, Conner J A, Spray D C, Bennett M V L (1989). Hepatocytegap junctions are permeable to a second messenger, inositol 1,4,5-triphosphate and to calcium ions. Proc Natl Acad Sci USA, 86, 2708-12.
155. Sakamoto H, Oyamada M, Enomoto K, Mori M (1992). Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis. Jpn J Cancer Res, 83, 1210-5.
156. Satoh K, Hatayama I, Tateoka N, et al (1989). Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis, 10, 2107-11.
157. Satoh K, Kitahara A, Soma Y, Hatayama I, Sato K (1985). Purification, induction and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical carcinogenesis. Proc Natl Acad Sci USA, 82, 3964-8.
158. Scholze W, Schutze K, Kunz W, Schwarz M (1990). Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules. Cancer Res, 50, 7015-22.
159. Scholz W, Schutze K, Kunz W, Schwarz M (1990). Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules. Cancer Res, 50, 7015-22.
160. Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J, et al (1983). Promotion of spontaneous preneoplastic cells as a possible explanataion of tumor promotion by nonmutagenic compounds. Cancer Res, 43, 839-44.
161. Seelmann-Eggebert G, Mayer D, Mecke D, Bannasch P (1987). Expression and regulation of glycogen phosphorylase in preneoplastic and neoplastic hepatic lesions in rats. Virchows Arch B Cell Pathol, 53, 44-51.
162. Simile M M, Pascale R, De Miglio M R (1994). Correlation between S-adenosyl-L-methionine content and production of cmyc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Cancer Letters, 79, 9-16.
163. Solt D B, Farber E (1976). New principle for the analysis of chemical carcinogenesis. Nature, 263, 702-3.
164. Sorensen H N, Gautik K M, Bremer J, Spydevold O (1992). Induction of the three peroxisomal beta-oxidation enzymes is synergistically regulated by dexamethasone and fatty acids, and counteracted by insulin in Morris 7800C1 hepatoma cells in culture. Eur J Biochem, 208, 705-11.
165. Squire R A, Levitt M H (1975). Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res, 35, 3214-223.
166. Stark A-A (1991). Oxidative metabolism of glutathione by gglutamyl transpeptidase and peroxisomal proliferation: the relevance to hepatocarcinogenesis. A hypothesis. Mutagenesis, 6, 241-5.
167. Stark A-A, Russell J J, Langenbach R, et al (1994). Localization of oxidative damage by a glutathione-g-glutamyl transpeptidase system in preneoplastic lesions in sections of livers from carcinogen-treated rats. Carcinogenesis, 15, 343-8.
168. Starzl T E, Porter K A, Kashiwagi N, Putnam C W (1975). Portal hepatotrophic factors, diabetes mellitus,and acute liver atrophy, hypertrophy, and regeneration. Surg Gynecol Obstet, 141, 843-58.
169. Steineger H H, Sorensen H N, Tugwood J D (1994). Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty-acid-induced transcription. Eur J Biochem, 225, 967-74.
170. Stitzel K A, Horn P A, Ezra M F (1990). Spontaneous basophilic foci of hepatocellular alteration in Fischer 344 rats do not exclude iron. Carcinogenesis, 11, 2253-4.
171. Stout D L, Becker F F (1987). Heme enzyme patterns in rat liver nodules and tumors. Cancer Res, 47, 963-6.
172. Stumpf H, Bannasch P (1994). Overexpression of glucose-6-phosphate dehydrogenase in rat preneoplasia and neoplasia. Int J Oncol, 5, 1255-60.
173. Su Q, Benner A, Hofmann WJ (1997). Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia.Virchows Arch, 431, 391-406
174. Su T-S, Tasi T-F, Chi C-W, Han S-H, Chou C-K (1990). Elevation of facilitative glucose-transporter messenger RNA in human hepatocellular carcinoma. Hepatology, 11, 118-22.
175. Sugie S, Yoshimi N, Tanaka T, Mori H, Williams G M (1994). Alterations of nuclear pores in preneoplastic and neoplastic lesions induced by 2-acetylaminofluorene. Carcinogenesis, 15, 95-8.
176. Suzuki S, Satoh K, Nakano H, et al (1995). Lack of correlated expression between the glutathione S-transferase P-form and the oncogene products c-Jun and c-Fos in rat tissues and preneoplastic hepatic foci. Carcinogenesis, 16, 567-71.
177. Tanno S, Ogawa K (1994). Abundant TGFa precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis, 15, 1689-94.
178. Taper H S, Bannasch P (1976). Histochemical correlation between glycogen, nucleic acids and nucleases in preneoplastic lesions of rat liver after short-term administration of Nnitrosomorpholine. Z Krebsforsch, 87, 53-65.
179. Tatematsu M, Mera Y, Ito N, Satoh K, Sato K (1985). Relative merits of immunohistochemical demonstration of placental, A, B and C forms of glutathione S-transferase as markers of altered foci during liver carcinogenesis. Carcinogenesis, 6, 1621-6.
180. Thomas H, Schladt L, Knehr M, Oesch F (1989). Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal beta-oxidation. Biochem. Pharmacol, 38, 4291-7.
181. Toshkov I, Chisari F V, Bannasch P (1994). Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology, 20, 1162-72.
182. Toshkov I, Hacker H J, Roggendorf M, Bannasch P (1990). Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus. J Cancer Res Clin Oncol, 116, 581-90.
183. Tsuda H, Asamoto M, Baba H, et al (1995). Cell proliferation and advancement of hepatocarcinogenesis are associated with a decrease in connexin 32 expression. Carcinogenesis, 16, 101-5.
184. Tsuda H, Asamoto M, Iwahori Y, et al (1996) Decreased connexin 32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver. Carcinogenesis, 17, 2441-8.
185. Tsuda H, Hirohashi S, Shimasato Y, Terada M, Hasegawa M (1988). Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology, 95, 1664-6.
186. Tsuda H, Moore M A, Asamoto M, et al (1987). Immunohistochemically demonstrated altered expression of cytochrome P-450 molecular forms and epoxide hydrolase in N-ethylhydroxyethylnitrosamine-induced rat kidney and liver lesions. Carcinogenesis, 8, 711-8.
187. Tsuda H, Moore M A, Asamoto M, et al (1988). Effect of modifying agents on the phenotypic expression of cytochrome P-450, glutathione S-transferase molecular forms, microsomal epoxide hydrolase, glucose-6-phosphate dehydrogenase and gamma glutamyltranspeptidase in rat liver preneoplastic lesions.Carcinogenesis, 9, 547-54.
188. Tsuda H, Ozaki K, Uwagawa S, et al (1992). Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver lesions in rats. Jpn J Cancer Res, 83, 1154-65.
189. Tsuji S, Ogawa K, Takasaka H, Sonoda T, Mori M (1988). Clonal origin of γ-glutamyl transpeptidase-positive hepatic lesions induced by initiation-promotion in ornithine carbamoyltransferase mosaic mice. Jpn J Cancer Res (Gann), 79, 148-51.
190. Ueno T, Takahashi K, Matsuguchi T, et al (1988). Reactivation of ratinsulin-like growth factor II gene during hepatocarcinogenesis. Carcinogenesis, 9, 1779-83.
191. Ungar H, Adler JH (1978). The histogenesis of hepatoma occurring spontaneously in a strain of sand rats (Psammomys ebesus). Am J Pathol, 90, 399-410.
192. Weber E, Bannasch P (1994). Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine. Carcinogenesis, 15, 1219-26.
193. Weber E, Bannasch P (1994). Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to Nnitrosomorpholine. Carcinogenesis, 15, 1227-34.
194. Weber E, Bannasch P (1994). Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Carcinogenesis, 15, 1235-42.
195. Weber E, Moore M A, Bannasch P (1988). Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell neoplastic nodules in rat liver after combined treatment with dehydroepiandrosterone and Nnitrosomorpholine. Carcinogenesis, 9, 1049-54.
196. Williams E D, Wareham K A, Howell S (1983). Direct evidence for the single cell origin of mouse liver tumors. Br J Cancer, 47, 723-6.
197. Williams G M, Klaiber M, Parker S E, Farber E (1976). Nature of early appearing carcinogen induced liver lesions resistant to iron accumulation. J Natl Cancer Inst, 57, 157-67.
198. Wu J, Lindstrom P, Danielsson A, Sehlin J (1994), Insulin secretion in pancreatic islets from rats with cirrhosis. J Hepatol, 21, 332-339.
199. Yamaguchi S, Hakoi K, Ozaki K, et al (1993). Number of simultaneously expressed enzyme alterations correlates with progression of N-ethyl-N-hydroxyethylnitrosamine-induced hepatocarcinogenesis in rats. Jpn J Cancer Res, 84, 1237-44.
200. Yang D, Alt E, Rogler C E (1993). Co-ordinate expression of Nmyc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res, 53, 2020-7.
201. Yokoyama Y, Tsuchida S, Hatayama I, Sato K (1993). Lack of peroxisomal enzyme inducibility in rat hepatic preneoplastic lesions induced by mutagenic carcinogens: contrasted expression of glutathione S-transferase P form and enoyl CoA hydratase. Carcinogenesis, 14, 393-398.
202. Zerban H, Rabes H M, Bannasch P (1989). Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis. J Cancer Res Clin Oncol, 115, 329-34.